Cargando…
Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense
The Nrf2/Keap1 axis plays a complex role in viral susceptibility, virus-associated inflammation and immune regulation in host cells. However, whether or how the Nrf2/Keap1 axis is involved in the interactions between equine lentiviruses and their hosts remains unclear. Here, we demonstrate that the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863222/ https://www.ncbi.nlm.nih.gov/pubmed/35139135 http://dx.doi.org/10.1371/journal.ppat.1009986 |
_version_ | 1784655191642996736 |
---|---|
author | Wang, Yan Ma, Guanqin Wang, Xue-Feng Na, Lei Guo, Xing Zhang, Jiaqi Liu, Cong Du, Cheng Qi, Ting Lin, Yuezhi Wang, Xiaojun |
author_facet | Wang, Yan Ma, Guanqin Wang, Xue-Feng Na, Lei Guo, Xing Zhang, Jiaqi Liu, Cong Du, Cheng Qi, Ting Lin, Yuezhi Wang, Xiaojun |
author_sort | Wang, Yan |
collection | PubMed |
description | The Nrf2/Keap1 axis plays a complex role in viral susceptibility, virus-associated inflammation and immune regulation in host cells. However, whether or how the Nrf2/Keap1 axis is involved in the interactions between equine lentiviruses and their hosts remains unclear. Here, we demonstrate that the Nrf2/Keap1 axis was activated during EIAV infection. Mechanistically, EIAV-Rev competitively binds to Keap1 and releases Nrf2 from Keap1-mediated repression, leading to the accumulation of Nrf2 in the nucleus and promoting Nrf2 responsive genes transcription. Subsequently, we demonstrated that the Nrf2/Keap1 axis represses EIAV replication via two independent molecular mechanisms: directly increasing antioxidant enzymes to promote effective cellular resistance against EIAV infection, and repression of Rev-mediated RNA transport through direct interaction between Keap1 and Rev. Together, these data suggest that activation of the Nrf2/Keap1 axis mediates a passive defensive response to combat EIAV infection. The Nrf2/Keap1 axis could be a potential target for developing strategies for combating EIAV infection. |
format | Online Article Text |
id | pubmed-8863222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88632222022-02-23 Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense Wang, Yan Ma, Guanqin Wang, Xue-Feng Na, Lei Guo, Xing Zhang, Jiaqi Liu, Cong Du, Cheng Qi, Ting Lin, Yuezhi Wang, Xiaojun PLoS Pathog Research Article The Nrf2/Keap1 axis plays a complex role in viral susceptibility, virus-associated inflammation and immune regulation in host cells. However, whether or how the Nrf2/Keap1 axis is involved in the interactions between equine lentiviruses and their hosts remains unclear. Here, we demonstrate that the Nrf2/Keap1 axis was activated during EIAV infection. Mechanistically, EIAV-Rev competitively binds to Keap1 and releases Nrf2 from Keap1-mediated repression, leading to the accumulation of Nrf2 in the nucleus and promoting Nrf2 responsive genes transcription. Subsequently, we demonstrated that the Nrf2/Keap1 axis represses EIAV replication via two independent molecular mechanisms: directly increasing antioxidant enzymes to promote effective cellular resistance against EIAV infection, and repression of Rev-mediated RNA transport through direct interaction between Keap1 and Rev. Together, these data suggest that activation of the Nrf2/Keap1 axis mediates a passive defensive response to combat EIAV infection. The Nrf2/Keap1 axis could be a potential target for developing strategies for combating EIAV infection. Public Library of Science 2022-02-09 /pmc/articles/PMC8863222/ /pubmed/35139135 http://dx.doi.org/10.1371/journal.ppat.1009986 Text en © 2022 Wang et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Wang, Yan Ma, Guanqin Wang, Xue-Feng Na, Lei Guo, Xing Zhang, Jiaqi Liu, Cong Du, Cheng Qi, Ting Lin, Yuezhi Wang, Xiaojun Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title | Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title_full | Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title_fullStr | Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title_full_unstemmed | Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title_short | Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense |
title_sort | keap1 recognizes eiav early accessory protein rev to promote antiviral defense |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863222/ https://www.ncbi.nlm.nih.gov/pubmed/35139135 http://dx.doi.org/10.1371/journal.ppat.1009986 |
work_keys_str_mv | AT wangyan keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT maguanqin keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT wangxuefeng keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT nalei keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT guoxing keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT zhangjiaqi keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT liucong keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT ducheng keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT qiting keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT linyuezhi keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense AT wangxiaojun keap1recognizeseiavearlyaccessoryproteinrevtopromoteantiviraldefense |